Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population – A prospective, multi-center, observational study (BLAST 1)

Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?

(2018) Anouk E. Muller et al.   DRUGS

Individualising Therapy to Minimize Bacterial Multidrug Resistance

(2018) A. J. Heffernan et al.   DRUGS

Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study

(2015) Angela Huttner et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

(2014) T W Felton et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units

(2014) G. Wong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data

(2014) Thomas P Van Boeckel et al.   LANCET INFECTIOUS DISEASES

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective Study

(2012) Bhavik M. Patel et al.   THERAPEUTIC DRUG MONITORING

The rising problem of antimicrobial resistance in the intensive care unit

(2011) Nele Brusselaers et al.   Annals of Intensive Care

Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept

(2010) Jason A. Roberts et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Prospective Determination of Serum Ceftazidime Concentrations in Intensive Care Units

(2010) Gerald Aubert et al.   THERAPEUTIC DRUG MONITORING

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Creatinine Kinetics and the Definition of Acute Kidney Injury

(2009) S. S. Waikar et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis

(2009) Brett H Heintz et al.   PHARMACOTHERAPY

Pharmacokinetic and Pharmacodynamic Properties of Meropenem

(2008) David P. Nicolau   CLINICAL INFECTIOUS DISEASES

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS